Fig. 1From: Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutationMicroscopic and immunohistochemical findings of the tumor. a Lossely-arranged central cells and hypercromatic peripheral cells (H&E; 200X). b Immunohistochemical staining for p63 (DAB; 200X). c Immunohistochemical staining for Ki67 predominantly staining cells located in the peripheral layerBack to article page